This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and gently massage the ointment. Wash your hands after applying, unless hands are the affected area.
Cloderm gm Ointment is a combination of three medicines: Clobetasol Topical, Gentamicin Topical and Miconazole Topical which treat skin infections. Clobetasol Topical is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen and itchy. It does cure the condition but provides temporary relief of symptoms. Gentamicin Topical is an antibiotic which kills bacteria by preventing the synthesis of essential proteins required by bacteria to carry out vital functions. Miconazole Topical is an antifungal which stops the growth of fungi by preventing them from forming their own protective covering.
Cloderm gm Ointment may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Cloderm gm Ointment is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Cloderm gm Ointment may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
There is limited information available on the use of Cloderm gm Ointment in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Cloderm gm Ointment in patients with liver disease. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Cloderm gm Ointment. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 6th Feb 2018.